PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PanGenomic Health Inc. has announced that the British Columbia Securities Commission issued a management cease trade order due to the company’s delay in filing its annual financial statements. The company, which is working with its auditors, expects to complete the filings by June 28, 2024, after securing debt financing to settle outstanding auditor fees. Meanwhile, the company’s CEO and CFO are restricted from trading company securities, although regular shareholders remain unaffected.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.